World Journal of Surgery

, Volume 34, Issue 3, pp 500–513 | Cite as

Evidence-based Guidelines for Perioperative Management of Diabetes in Cardiac and Vascular Surgery

  • Jennifer Wong
  • Sophia Zoungas
  • Chris Wright
  • Helena Teede
Article

Abstract

Background

Management of patients with hyperglycaemia undergoing vascular and cardiac surgery is important, with mounting evidence that hyperglycaemia in this setting is associated with worse outcomes. Evidence-based guidelines for the management of these patients have been limited.

Methods/Results

Our institution was aware of the lack of standardization of care in this growing population group and formed a multidisciplinary guideline development group to develop evidence-based guidelines to standardize the perioperative management of hyperglycaemia.

Conclusion

This series of articles outlines the process of developing evidence-based guidelines and the recommendations for perioperative management of patients with hyperglycaemia and diabetes undergoing cardiac and vascular surgery at our institution.

Abbreviations

ADA

American Diabetes Association

BSL

Blood sugar level

CABG

Coronary artery bypass grafting

CVVHDF

Continuous veno-venous haemodialysis and filtration

CII

Continuous insulin infusion

DNE

Diabetes Nurse Educator

FBG

Fasting blood glucose

eGFR

Estimated glomerular filtration rate

GDG

Guideline Development Group

GIK

Potassium, Insulin and glucose infusion

HbA1c

Glycosylated haemoglobin

ICU

Intensive care unit

IFG

Impaired fasting glucose

IGT

Impaired glucose tolerance

NHMRC

National Health and Medical Research Council

OGTT

Oral glucose tolerance test

RBG

Random blood glucose

TPN

Total parenteral nutrition

WHO

World Health Organisation

References

  1. 1.
    World Health Organization (WHO) (2006) Global strategy on Diet, Physical Activity and Health. Diabetes. http://www.who.int/dietphysicalactivity/publications/facts/diabetes/en/. Accessed September 19, 2006
  2. 2.
    Dunstan DW, Zimmet PZ, Welborn T, on behalf of the AusDiab Steering Committee et al (2001) Diabesity and associated disorders in Australia-2000. The accelerating epidemic. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab). International Diabetes Institute, MelbourneGoogle Scholar
  3. 3.
    Latham R, Lancaster A, Covington J et al (2001) The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 22(10):607–612CrossRefPubMedGoogle Scholar
  4. 4.
    Lauruchskat AH (2005) Prevalence and risks of undiagnosed diabetes mellitus in patients undergoing CABG. Circulation 112(16):2397–2402CrossRefGoogle Scholar
  5. 5.
    Swenne CL, Lindholm C, Borowiec J et al (2005) Peri-operative glucose control and development of surgical wound infections in patients undergoing coronary artery bypass graft. J Hosp Infect 61:201–212CrossRefPubMedGoogle Scholar
  6. 6.
    Dunstan DW, Zimmet PZ, Welborn TA et al (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 25:829–834CrossRefPubMedGoogle Scholar
  7. 7.
    Consortium DAGD (2005) National evidence based guidelines for the management of type 2 diabetes, 2nd edn. National Health and Medical Research Council, CanberraGoogle Scholar
  8. 8.
    (1998) Standards of medical care for patients with diabetes mellitus. Diabetes Care 21(Suppl 1):23S–31SGoogle Scholar
  9. 9.
    Ten facts about Diabetes. http://www.mydr.com.au/default_new.asp?article=2885. Accessed September 19, 2006
  10. 10.
    Uusitupa MI, Niskanen LK, Sitonen O et al (1993) Ten year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36(11):1175–1184CrossRefPubMedGoogle Scholar
  11. 11.
    Hypertension in Diabetes Study Group (1995) Prevalence of hypertension in newly presenting Type 2 diabetic patients and the association of risk factors for cardiovascular and diabetic complications. J Hypertension 11:309–317Google Scholar
  12. 12.
    Kadoi Y, Saito S, Fujita N et al (2005) Risk factors for cognitive dysfunction after coronary artery bypass graft surgery in patients with type 2 diabetes. J Thorac Cardiovasc Surg 129(3):576–583CrossRefPubMedGoogle Scholar
  13. 13.
    NBPA Committee (2004) Hypertension Management Guide for Doctors, 2004 Guideline. Heart Foundation, SydneyGoogle Scholar
  14. 14.
    Guvener M, Pasaoglu I, Demircin M et al (2002) Perioperative hyperglycaemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocr J 49(5):531–537CrossRefPubMedGoogle Scholar
  15. 15.
    Trick WE, Scheckler WE, Tokars JI et al (2000) Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg 119(1):108–114CrossRefPubMedGoogle Scholar
  16. 16.
    Cohen O, Dankner R, Chetrit A et al (2003) Multidisciplinary intervention for control of diabetes in patients undergoing coronary artery bypass graft (CABG). Cardiovasc Surg 11(3):195–200CrossRefPubMedGoogle Scholar
  17. 17.
    Salpeter SR, Greyber E, Pasternak GA et al. (2006) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Library, CD002967Google Scholar
  18. 18.
    DAGD Consortium (2009) National evidence based guidelines for blood glucose control in type 2 diabetes. National Health and Medical Research Council, CanberraGoogle Scholar
  19. 19.
    Gandhi GY, Nuttall GA, Abel MD et al (2007) Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery. Ann Intern Med 146:233–243PubMedGoogle Scholar
  20. 20.
    Ouattara A, Lecomte P, Le Manach Y et al (2005) Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients. Anesthesiology 103(4):687–694CrossRefPubMedGoogle Scholar
  21. 21.
    Gandhi GY, Nuttall GA, Abel MD et al (2005) Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 80(7):862–866CrossRefPubMedGoogle Scholar
  22. 22.
    Whipple AO, Frank VO (1937) Adenoma of islet cell tumours with hyperinsulinism. Am J Pathol 14:125–138Google Scholar
  23. 23.
    Vriesendorp TM, DeVries JH, Holleman F et al (2005) The use of two continuous glucose sensors during and after surgery. Diabetes Technol Ther 7(2):315–322CrossRefPubMedGoogle Scholar
  24. 24.
    Lazar HL, Chipkin SR, Fitzgerald CA et al (2004) Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events [see comment]. Circulation 109(12):1497–1502CrossRefPubMedGoogle Scholar
  25. 25.
    Gavin LA (1989) Management of diabetes mellitus during surgery. West J Med 151:1525–1529Google Scholar
  26. 26.
    Rady MY, Johnson DJ, Patel BM et al (2005) Influence of individual characteristics on outcome of glycaemic control in intensive care unit patients with and without diabetes mellitus. Mayo Clin Proc 80(12):1558–1567CrossRefPubMedGoogle Scholar
  27. 27.
    Whitcomb BW, Pradhan EK, Pittas AG et al (2005) Impact of admission hyperglycaemia on hospital mortality in various intensive care unit populations. Crit Care Med 33(12):2772–2777CrossRefPubMedGoogle Scholar
  28. 28.
    Freire AX, Bridges L, Umpierrez GE et al (2005) Admission hyperglycaemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest 128(5):3109–3116CrossRefPubMedGoogle Scholar
  29. 29.
    Christiansen C, Toft P, Jorgensen HS et al (2004) Hyperglycaemia and mortality in critically ill patients: a prospective study. Intensive Care Med 30:1685–1688CrossRefPubMedGoogle Scholar
  30. 30.
    Zerr KJ, Furnary AP, Grunkemeier GL et al (1997) Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 63:356–361CrossRefPubMedGoogle Scholar
  31. 31.
    Carr JM, Sellke FW, Fey M et al (2005) Implementing tight glucose control after coronary bypass surgery. Ann Thorac Surg 80:902–909CrossRefPubMedGoogle Scholar
  32. 32.
    Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359–1367CrossRefPubMedGoogle Scholar
  33. 33.
    Furnary A, Wu Y, Bookin SO (2004) Effect of hyperglycaemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract 10(2):21–33PubMedGoogle Scholar
  34. 34.
    NICE-SUGAR Study Investigators (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360(13):1283–1297CrossRefGoogle Scholar
  35. 35.
    Gore MO, McGuire DK (2009) The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context. Diab Vasc Dis Res 6(1):53–55CrossRefPubMedGoogle Scholar
  36. 36.
    UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).[see comment]. Lancet 352(9131):837-853 [erratum: Lancet 1999 Aug 14;354(9178):602]Google Scholar
  37. 37.
    Nissen SE, Wolski K (2007) Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356(24):2457–2471CrossRefPubMedGoogle Scholar
  38. 38.
    Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26(11):3160–3167CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2010

Authors and Affiliations

  • Jennifer Wong
    • 1
  • Sophia Zoungas
    • 2
    • 3
  • Chris Wright
    • 4
  • Helena Teede
    • 5
    • 6
  1. 1.Diabetes and Research UnitDandenong Hospital, Southern HealthDandenongAustralia
  2. 2.The George Institute for International HealthSydneyAustralia
  3. 3.Monash School of Public Health and Preventive MedicineMonash Institute of Health Services ResearchClaytonAustralia
  4. 4.Intensive Care Unit, Southern Health Victoria Australia
  5. 5.Diabetes and Research Unit, Southern HealthVictoria Australia
  6. 6.Monash Institute of Health Services ResearchJean Hailes’ Womens Health Research GroupMelbourne Australia

Personalised recommendations